SanReno Therapeutics

SanReno Therapeutics will primarily focus on the research, development, manufacturing, and commercialization of drugs in the field of nephrology and related diseases within Greater China. It is committed to providing internationally leading innovative treatments and clinical solutions to extend patients' lives and create a higher quality of healthy living.SanReno Therapeutics is a joint venture established by Pivotal bioVenture Partners China, the well-known U.S. healthcare fund Frazier Healthcare Partners, and Chinook Therapeutics, a clinical-stage biotechnology company.